vs
Side-by-side financial comparison of Agilent Technologies (A) and Allegion (ALLE). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.0B, roughly 1.7× Allegion). Agilent Technologies runs the higher net margin — 17.0% vs 13.4%, a 3.6% gap on every dollar of revenue. On growth, Allegion posted the faster year-over-year revenue change (9.7% vs 7.0%). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 3.5%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...
A vs ALLE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.0B |
| Net Profit | $305.0M | $138.1M |
| Gross Margin | 52.6% | 44.0% |
| Operating Margin | 19.6% | 18.9% |
| Net Margin | 17.0% | 13.4% |
| Revenue YoY | 7.0% | 9.7% |
| Net Profit YoY | -4.1% | -6.8% |
| EPS (diluted) | $1.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $1.0B | ||
| Q4 25 | $1.9B | $1.0B | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.7B | $1.0B | ||
| Q1 25 | $1.7B | $941.9M | ||
| Q4 24 | $1.7B | $945.6M | ||
| Q3 24 | $1.6B | $967.1M | ||
| Q2 24 | $1.6B | $965.6M |
| Q1 26 | $305.0M | $138.1M | ||
| Q4 25 | $434.0M | $147.5M | ||
| Q3 25 | $336.0M | $188.4M | ||
| Q2 25 | $215.0M | $159.7M | ||
| Q1 25 | $318.0M | $148.2M | ||
| Q4 24 | $351.0M | $144.1M | ||
| Q3 24 | $282.0M | $174.2M | ||
| Q2 24 | $308.0M | $155.4M |
| Q1 26 | 52.6% | 44.0% | ||
| Q4 25 | 53.2% | 44.5% | ||
| Q3 25 | 51.1% | 45.8% | ||
| Q2 25 | 51.9% | 45.6% | ||
| Q1 25 | 53.5% | 44.9% | ||
| Q4 24 | 53.9% | 44.1% | ||
| Q3 24 | 54.2% | 44.7% | ||
| Q2 24 | 54.4% | 44.4% |
| Q1 26 | 19.6% | 18.9% | ||
| Q4 25 | 23.8% | 20.3% | ||
| Q3 25 | 20.7% | 21.8% | ||
| Q2 25 | 18.0% | 21.5% | ||
| Q1 25 | 22.4% | 20.9% | ||
| Q4 24 | 24.0% | 19.5% | ||
| Q3 24 | 21.1% | 22.2% | ||
| Q2 24 | 23.1% | 21.6% |
| Q1 26 | 17.0% | 13.4% | ||
| Q4 25 | 23.3% | 14.3% | ||
| Q3 25 | 19.3% | 17.6% | ||
| Q2 25 | 12.9% | 15.6% | ||
| Q1 25 | 18.9% | 15.7% | ||
| Q4 24 | 20.6% | 15.2% | ||
| Q3 24 | 17.9% | 18.0% | ||
| Q2 24 | 19.6% | 16.1% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $1.70 | ||
| Q3 25 | $1.18 | $2.18 | ||
| Q2 25 | $0.75 | $1.85 | ||
| Q1 25 | $1.11 | $1.71 | ||
| Q4 24 | $1.23 | $1.65 | ||
| Q3 24 | $0.97 | $1.99 | ||
| Q2 24 | $1.05 | $1.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $308.9M |
| Total DebtLower is stronger | $3.0B | $2.0B |
| Stockholders' EquityBook value | $6.9B | $2.1B |
| Total Assets | $12.8B | $5.3B |
| Debt / EquityLower = less leverage | 0.44× | 0.97× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $308.9M | ||
| Q4 25 | $1.8B | $356.2M | ||
| Q3 25 | $1.5B | $302.7M | ||
| Q2 25 | $1.5B | $656.8M | ||
| Q1 25 | $1.5B | $494.5M | ||
| Q4 24 | $1.3B | $503.8M | ||
| Q3 24 | $1.8B | $878.9M | ||
| Q2 24 | $1.7B | $747.5M |
| Q1 26 | $3.0B | $2.0B | ||
| Q4 25 | $3.0B | $2.0B | ||
| Q3 25 | $3.4B | $2.1B | ||
| Q2 25 | $3.3B | $2.1B | ||
| Q1 25 | $3.3B | $2.0B | ||
| Q4 24 | $3.3B | $2.0B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.1B | $2.4B |
| Q1 26 | $6.9B | $2.1B | ||
| Q4 25 | $6.7B | $2.1B | ||
| Q3 25 | $6.4B | $1.9B | ||
| Q2 25 | $6.1B | $1.8B | ||
| Q1 25 | $6.0B | $1.6B | ||
| Q4 24 | $5.9B | $1.5B | ||
| Q3 24 | $5.9B | $1.6B | ||
| Q2 24 | $6.2B | $1.4B |
| Q1 26 | $12.8B | $5.3B | ||
| Q4 25 | $12.7B | $5.2B | ||
| Q3 25 | $12.2B | $5.2B | ||
| Q2 25 | $12.2B | $4.9B | ||
| Q1 25 | $11.9B | $4.6B | ||
| Q4 24 | $11.8B | $4.5B | ||
| Q3 24 | $11.0B | $5.0B | ||
| Q2 24 | $10.9B | $4.8B |
| Q1 26 | 0.44× | 0.97× | ||
| Q4 25 | 0.45× | 0.96× | ||
| Q3 25 | 0.53× | 1.07× | ||
| Q2 25 | 0.55× | 1.16× | ||
| Q1 25 | 0.56× | 1.24× | ||
| Q4 24 | 0.57× | 1.33× | ||
| Q3 24 | 0.36× | 1.53× | ||
| Q2 24 | 0.34× | 1.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $101.3M |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | 2.0% |
| Cash ConversionOCF / Net Profit | 0.88× | 0.73× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | $101.3M | ||
| Q4 25 | $545.0M | $240.1M | ||
| Q3 25 | $362.0M | $229.5M | ||
| Q2 25 | $221.0M | $209.7M | ||
| Q1 25 | $431.0M | $104.5M | ||
| Q4 24 | $481.0M | $219.0M | ||
| Q3 24 | $452.0M | $231.9M | ||
| Q2 24 | $333.0M | $173.0M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $200.5M | ||
| Q3 25 | $259.0M | $209.8M | ||
| Q2 25 | $107.0M | $192.0M | ||
| Q1 25 | $334.0M | $83.4M | ||
| Q4 24 | $388.0M | $194.9M | ||
| Q3 24 | $360.0M | $212.0M | ||
| Q2 24 | $230.0M | $152.1M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 19.4% | ||
| Q3 25 | 14.9% | 19.6% | ||
| Q2 25 | 6.4% | 18.8% | ||
| Q1 25 | 19.9% | 8.9% | ||
| Q4 24 | 22.8% | 20.6% | ||
| Q3 24 | 22.8% | 21.9% | ||
| Q2 24 | 14.6% | 15.8% |
| Q1 26 | 5.2% | 2.0% | ||
| Q4 25 | 5.0% | 3.8% | ||
| Q3 25 | 5.9% | 1.8% | ||
| Q2 25 | 6.8% | 1.7% | ||
| Q1 25 | 5.8% | 2.2% | ||
| Q4 24 | 5.5% | 2.5% | ||
| Q3 24 | 5.8% | 2.1% | ||
| Q2 24 | 6.5% | 2.2% |
| Q1 26 | 0.88× | 0.73× | ||
| Q4 25 | 1.26× | 1.63× | ||
| Q3 25 | 1.08× | 1.22× | ||
| Q2 25 | 1.03× | 1.31× | ||
| Q1 25 | 1.36× | 0.71× | ||
| Q4 24 | 1.37× | 1.52× | ||
| Q3 24 | 1.60× | 1.33× | ||
| Q2 24 | 1.08× | 1.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
